Component
Assayed methylated and glucuronidated nasunin metabolite panel
Assayed methylated and glucuronidated nasunin metabolite panel. Species, exposure and limitations are retained in each linked claim.
1 recorded relationships. Experimental role, claim status and evidence remain attached to each record.
How nutrients influence it
Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.
Other things that act on it
Enzymes, hormones, genes, and other components with a recorded effect. These are not nutrients, so they do not count toward the arrows above. Each finding names the chapter that recorded it.
How nutrients reach it in more than one step
Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.
Tracing routes…
What it does
Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.
What acts on it
The examined methylated analogues and extended glucuronides were not detected in plasma or urine.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/nasunin-research/16848510.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "72244518913802f8f2018e3e6e7add9914294e49c58b9e9733c26a550e86479a", "start_char": 0, "end_char": 1308, "text_sha256": "72244518913802f8f2018e3e6e7add9914294e49c58b9e9733c26a550e86479a"}
- experimental_model
- Oral isomer pharmacokinetics with chromatographic metabolite analysis
- exposure
- Oral purified cis/trans nasunin; plasma follow-up to 8 h
- limitations
- Dose-normalized Cmax/AUC comparison is not absolute oral bioavailability. Nondetection applies to the tested analytes, method and window; no human or blood-brain-barrier conclusion.
- nutrient_topic
- Nasunin research collection; topical membership is not evidence of a direct dietary effect. · Nasunin
- organism
- Rats
- plain_language
- The study did not find those particular metabolites.
- primary_references
- [nasunin-p16848510] Gastrointestinal uptake of nasunin, acylated anthocyanin in eggplant. (2006). https://pubmed.ncbi.nlm.nih.gov/16848510/ DOI: 10.1021/jf060238s
- tissue_or_cell_type
- Plasma and urine
Nasunin: identity, redox chemistry and nutrient connections (2026-09-17) · lines 770–781
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Oral isomer pharmacokinetics with chromatographic metabolite analysis · source_derived_draft · unverified_draft
### nasunin-conjugate-nondetection The examined methylated analogues and extended glucuronides were not detected in plasma or urine. Condition category: normal nutrient_topic: Nasunin research collection; topical membership is not evidence of a direct dietary effect. plain_language: The study did not find those particular metabolites. organism: Rats tissue_or_cell_type: Plasma and urine experimental_model: Oral isomer pharmacokinetics with chromatographic metabolite analysis limitations: Dose-normalized Cmax/AUC comparison is not absolute oral bioavailability. Nondetection applies to the tested analytes, method and window; no human or blood-brain-barrier conclusion. exposure: Oral purified cis/trans nasunin; plasma follow-up to 8 h evidence_span: {"source_cache": "artifacts/nasunin-research/16848510.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "72244518913802f8f2018e3e6e7add9914294e49c58b9e9733c26a550e86479a", "start_char": 0, "end_char": 1308, "text_sha256": "72244518913802f8f2018e3e6e7add9914294e49c58b9e9733c26a550e86479a"} [nasunin-p16848510] Gastrointestinal uptake of nasunin, acylated anthocyanin in eggplant. (2006). https://pubmed.ncbi.nlm.nih.gov/16848510/ DOI: 10.1021/jf060238s
Complete structured claim and evidence
The events it takes part in
A mechanism often involves more than two components. These are the full events, with every participant and its role.
Situations it appears in
Low-supply and faulty-machinery situations recorded in the chapters where this component plays a part.
In the sources
Preserved passages that mention this component, quoted exactly. Open one to read it in context.
Open hypotheses
Proposed ideas that involve this component. They are labeled as hypotheses and do not change any recorded statement.
This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.